The Healthcare Channel

Book Review: Dragnet Nation by Julia Angwin

Posted on March 2, 2014 by admin

March 2, 2014- By Steven E. Greer, MD

Author of Dragnet Nation, Julia Angwin, won her Pulitzer Prize while working for the Wall Street Continue reading →

Posted in - Reviews, books, devices | Leave a comment

The serious adverse events caused by topical testoserone

Posted on March 1, 2014 by admin

March 1, 2014 Continue reading →

Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA | Leave a comment

FDA investigated by congress for spying on whistleblowers

Posted on February 26, 2014 by admin

Update February 26, 2014- Senator Grassley convened an oversight hearing in the senate, and also Continue reading →

Posted in Congress, FDA | Leave a comment

Tenets of the Palo Alto business model

Posted on February 24, 2014 by admin

February 24, 2014- By Steven E. Greer, MD

With so many young kids becoming billionaires overnight in Silicon Valley, you might be thinking Continue reading →

Posted in - Opinion | Leave a comment

The FDA discusses Brilinta

Posted on February 4, 2014 by admin

February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal Continue reading →

Posted in - Pharma, Cardiology, FDA | Leave a comment

Why the lack of outrage over smoking depicted in film and television?

Posted on January 20, 2014 by admin

January 20, 2014

To Senators Dick Durbin, Richard Blumenthal, Sherrod Brown, and Edward Markey Continue reading →

Posted in - Opinion, Congress, FDA | Leave a comment

Alex Rodriguez’s PED schedule

Posted on January 12, 2014 by admin

January 12, 2014- By Steven E. Greer, MD

CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor Continue reading →

Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology | Leave a comment

Twitter interview with banned-for-life Wall Street tech analyst Henry Blodget

Posted on January 11, 2014 by admin

January 11, 2014- By Steven E. Greer, MD

Disgraced Wall Street sell-side technology sector analyst, Henry Blodget, who was banned for life by Continue reading →

Posted in - Opinion, Congress | Leave a comment

Harvard professors feel the impact in their pocketbooks of the ACA law that they helped pass

Posted on January 5, 2014 by admin

Update January 5, 2014- This is now being reported in the New York Times, two-months after our reporting. Continue reading →

Posted in - Opinion, CMS, Harvard | Leave a comment

The biggest healthcare stories of 2013

Posted on December 23, 2013 by admin

December 23, 2013- By Steven E. Greer, MD

Like a broken record, 2013 was yet another tough year for healthcare companies. Several forces are Continue reading →

Posted in - Opinion, - The Weekly Summary | Leave a comment

Laws governing genetic tests

Posted on December 19, 2013 by admin

December 19, 2013– Interviewed by Steven E. Greer, MD

In Part 2 of our interview with Robert Klitzman, MD, from Columbia University, he discusses Continue reading →

Posted in Columbia, Congress, FDA, Genetics | Leave a comment

CBS allows TV doctor to make egregious claims about statins

Posted on November 29, 2013 by admin

Can a “calculator” really tell doctors who should be on Lipitor?

Nortin Hadler, MD: lack of evidence for widespread statin use

The risk of diabetes associated with statin drugs

“You’re telling me this now?” Why the news is suddenly critical of statins and antidepressants

Sanjay Kaul, MD: The Crestor JUPITER indication label expansion

Posted in - Pharma, Cardiology, Cedars Sinai | Leave a comment

The finances of TAVI: do prices have to come down?

Posted on November 8, 2013 by admin

November 8, 2013- Interviewed by Steven E. Greer, MD

William O’Neill, MD of Henry Ford discusses the finances of transapical aortic valve implantation (TAVI) and why the $30,000 pricetag for the devices should be closer to $5,000. He also discusses the overall market size for TAVI.

Posted in - Medical Devices, Cardiac surgery, Cardiology, CMS | Leave a comment

TAVI: Comparing CoreValve to Sapien

Posted on November 8, 2013 by admin

November 8, 2013- Interviewed by Steven E. Greer, MD

William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device, Continue reading →

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford | Leave a comment

New therapies for hepatitis C

Posted on November 6, 2013 by admin

November 6, 2013- Interviewed by Steven E. Greer, MD

In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care Continue reading →

Posted in - Biotech, - Pharma, Gastroenterology and liver, Infectious disease, UCLA | Leave a comment

The clinical hurdles to prescribing CGM

Posted on October 31, 2013 by admin

October 31, 2014– Interviewed by Steven E. Greer, MD

The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM) Continue reading →

Posted in - Medical Devices, CMS, Diabetes and endocrinology | Leave a comment

Did the GOP shut down the government just to please a special interest industry lobby?

Posted on October 19, 2013 by admin

October 19, 2013- By Steven E. Greer MD

The United States government was partially shut down for more than two weeks in October. Continue reading →

Posted in - Medical Devices, - Opinion, Congress | Leave a comment

The more we know, the more unnecessary President Bush’s stent seems

Posted on October 16, 2013 by admin

October 16, 2013 By Steven E. Greer, MD

A recent short article in an obscure Washington, DC wonky journal triggered national media Continue reading →

Posted in Cardiac surgery, Cardiology | Leave a comment

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

Posted on October 6, 2013 by admin

October 23, 2013- Interviewed by Steven E. Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Continue reading →

Posted in - Medical Devices, Diabetes and endocrinology, FDA | Leave a comment

A Bridge Too Far: Patient classifications for LVAD reimbursement

Posted on September 16, 2013 by admin

September 16, 2013- By Ashish Shah, MD, Cardiac transplant surgeon, The Johns Hopkins Medical Center

Left ventricular assist devices (LVADs) arose from the ashes of the total artificial heart era. Continue reading →

Posted in - Opinion, Cardiac surgery, CMS, Johns Hopkins | Leave a comment